Multiple endocrine neoplasia, type 2

  • Dec 10, 2018 www.onclive.com
    Direct Targeting of RET Aberrations Moves Closer to the Clinic – OncLive
    Read More
  • Nov 27, 2018 www.medscape.com
    ACC Consensus on New Diabetes Drugs to Reduce CV Outcomes – Medscape
    Read More
  • Nov 23, 2018 www.coherentnews.com
    Neuroendocrine Tumors Treatment Market Existing Trade Leaders, Revenue Metrics and Future Roadmap 2026 – Coherent News
    Read More
  • Nov 13, 2018 www.morgannewspaper.us
    Neuroendocrine Tumors Treatment Market 2018-2026 Market Positioning, Revenue, Growth Factors and Forecast Till 2026 – Morgan Newspaper USA
    Read More
  • Nov 06, 2018 www.openpr.com
    Neuroendocrine Tumor Treatment Market Show Significant Growth To 2026 By Global Top Players – Pfizer Inc, Novartis AG, Advanced Accelerator Applications, Tarveda Therapeutics, Progenics Pharmaceuticals, Inc., Dauntless Pharmaceuticals Inc. and Exelixis, I – openPR
    Read More
  • The Skinny on Commonly Prescribed Antiobesity Medications – Contemporary Clinic
    Read More
  • Oct 17, 2018 www.eurekalert.org
    Five distinguished individuals to be honored with highest American Cancer Society Award – EurekAlert
    Read More
  • Pleasanton Preps: TV30 honors High School Athletic Award winners – Pleasanton Weekly
    Read More
  • Aug 17, 2018 www.raredr.com
    Understanding Genetics to Develop Future Treatments for Rare Cancers – Rare Disease Report
    Read More

Connect. Empower. Inspire.